SS
RDY icon

Steve Schonfeld’s Dr. Reddy's Laboratories RDY Stock Holding History

Steve Schonfeld’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,475
Closed -$368K – 2510
2025
Q2 		$368K Buy
+24,475
New +$350K ﹤0.01% 1636
2023
Q4 		– Sell
-101,000
Closed -$1.35M – 2161
2023
Q3 		$1.35M Buy
101,000
+1,500
+2% +$20.3K 0.01% 926
2023
Q2 		$1.26M Buy
99,500
+75,500
+315% +$881K 0.01% 906
2023
Q1 		$273K Buy
+24,000
New +$259K ﹤0.01% 1410
2021
Q2 		– Sell
-24,000
Closed -$295K – 2244
2021
Q1 		$295K Buy
+24,000
New +$308K ﹤0.01% 1335
2017
Q2 		– Sell
-42,425
Closed -$341K – 742
2017
Q1 		$341K Buy
+42,425
New +$366K 0.03% 443

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steve Schonfeld's RDY Position: Q3 2025 in Review

Steve Schonfeld sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 24,475 shares — an estimated $368K sold.

Steve Schonfeld first reported a position in RDY in Q1 2017 and held it in 6 quarters. The position peaked at $1.35M in Q3 2023. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Steve Schonfeld reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 24,475 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $368K.
  • Steve Schonfeld first reported a position in Dr. Reddy's Laboratories in Q1 2017 and held it in 6 quarters.
  • Steve Schonfeld's Dr. Reddy's Laboratories position peaked at $1.35M in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.